Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis

被引:30
作者
Langdon, Kane [1 ]
Haleagrahara, Nagaraja [2 ]
机构
[1] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia
[2] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia
关键词
Abatacept; immune modulation; rheumatoid arthritis; T lymphocytes; therapeutics; AUTOIMMUNE-DISEASES; DENDRITIC CELLS; TGF-BETA; CTLA-4; EXPRESSION; THERAPY; ACTIVATION; MECHANISMS; CD28; DIFFERENTIATION;
D O I
10.1080/08830185.2018.1465943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The progressive damage in rheumatoid arthritis (RA) has been linked to an increase in inflammatory Th1/Th17 cells and a decrease in number or function of immunomodulatory regulatory T cells (Tregs). Many therapies that are effective in RA are shown to affect Th1/Th17 cells and/or Tregs. One such therapy, abatacept, utilizes a physiologic immunomodulatory molecule called cytotoxic lymphocyte antigen-4 (CTLA-4) which causes contact-dependent inhibition of inflammatory T-cell activation. Recent advances in CTLA-4 research has uncovered the method by which this occurs physiologically but the actions of the CTLA-4Ig fusion protein are still not fully understood. The reported effects of the drug on Treg population number and suppressor function have been very mixed. In this review, we will discuss the current literature surrounding the effects of abatacept in rheumatoid arthritis and explore potential explanations for the differences in results. Future opportunities in this area include contributions to a unified definition for different immune cell populations, LAG3(+) Tregs which may pose an avenue for further study or the stratification of patients with regards to their specific disease characteristics, resulting in optimized treatment for disease remission.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 50 条
[41]   Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders [J].
Zizzo, Gaetano ;
Gremese, Elisa ;
Ferraccioli, Gianfranco .
IMMUNOTHERAPY, 2018, 10 (09) :807-821
[42]   Rituximab and abatacept in rheumatoid arthritis [J].
Gomez Centeno, Toni .
REUMATOLOGIA CLINICA, 2009, 5 :77-81
[43]   Regulatory T-cell dysfunction and its implication for cell therapy [J].
Valentini, Nicolas ;
Cier, Christopher J. Requejo ;
Lamarche, Caroline .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 213 (01) :40-49
[44]   Migration and homeostasis of regulatory T cells in rheumatoid arthritis [J].
Kotschenreuther, Konstantin ;
Yan, Shuaifeng ;
Kofler, David M. .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[45]   Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE Trial [J].
Genovese, Mark C. ;
Pacheco Tena, Cesar ;
Covarrubias, Arturo ;
Leon, Gustavo ;
Mysler, Eduardo ;
Keiserman, Mauro ;
Valente, Robert ;
Nash, Peter ;
Abraham Simon-Campos, J. ;
Box, Jane ;
Legerton, Clarence William, III ;
Nasonov, Evgeny ;
Durez, Patrick ;
Delaet, Ingrid ;
Teng, Julie ;
Alten, Rieke .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) :629-639
[46]   Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis [J].
Pascart, Tristan ;
Philippe, Peggy ;
Drumez, Elodie ;
Deprez, Xavier ;
Cortet, Bernard ;
Duhamel, Alain ;
Houvenagel, Eric ;
Flipo, Rene-Marc .
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) :E358-E363
[47]   Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis [J].
Fukuyo, S. ;
Nakayamada, S. ;
Iwata, S. ;
Kubo, S. ;
Saito, K. ;
Tanaka, Y. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) :562-570
[48]   Update on the use of abatacept for the treatment of rheumatoid arthritis [J].
Vicente Rabaneda, Esther F. ;
Herrero-Beaumont, Gabriel ;
Castaneda, Santos .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (07) :599-621
[49]   Abatacept: A novel therapy approved for the treatment of patients with rheumatoid arthritis [J].
Lisa Lundquist .
Advances in Therapy, 2007, 24 :333-345
[50]   Abatacept: A novel treatment for moderate-to-severe rheumatoid arthritis [J].
Reynolds, Jennifer ;
Shojania, Kam ;
Marra, Carlo A. .
PHARMACOTHERAPY, 2007, 27 (12) :1693-1701